WHO ICTRP trial
Efficacy of Aswagandha and Mandookaparni in Manodwega (GAD) patients
CTRI/2017/07/009095 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/07/009095 |
|---|---|
| Public title | Efficacy of Aswagandha and Mandookaparni in Manodwega (GAD) patients |
| Scientific title | Clinical evaluation of A comprehensive Ayurvedic intervention in Manodwega (Generalized Anxiety Disorder) |
| Primary sponsor | Central council for Research in Ayurvedic sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Diagnosed cases of Generalized Anxiety Disorder based on DSM IV criteria Health Condition 2: F411- Generalized anxiety disorder |
| Interventions | Intervention1: GROUP I: Group I: 1. Ashvagandha churna (Bhava prakasha nighantu). In tablet form. Dose 1.5 gm (3 tablets of 500 mg each) twice daily Dosage form Tablet Route of Administration Oral Time of Administration Twice a day after… |
| Registration date | Jul 21, 2017 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: